Received Sep 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
possible wrong diluent; Menveo was reconstituted with sterile water; This non-serious case was reported by other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On an unknown date, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced inappropriate dose of vaccine administered (Verbatim: possible wrong diluent) and wrong solution used in drug reconstitution (Verbatim: Menveo was reconstituted with sterile water). The outcome of the inappropriate dose of vaccine administered and wrong solution used in drug reconstitution were not applicable. Additional Information: GSK Receipt Date: 12-AUG-2025 The reporter reported that there was a possible instance in which Menveo was reconstituted with sterile water instead of the provided reconstitution ingredients. Reporter asked if a revaccination was required to ensure adequate protection for the patient.